List view / Grid view
Market research suggests the new drug patent reforms in China,…
Market research suggests the new drug patent reforms in China, in addition to other regulatory changes, will incentivise innovative pharma research.
According to a report, supply disruption scares and price hikes…
According to a report, supply disruption scares and price hikes due to COVID-19 are a 'wake-up call' for India to reduce its dependence on China for APIs.
The Philippines’ 2019 Universal Health Care Act and regulatory tax…
The Philippines’ 2019 Universal Health Care Act and regulatory tax reforms open new avenues for the Indian pharmaceutical industry, according to new research.
